VYNE
Vyne Therapeutics Inc
Price:
0.95
USD
Volume:
91,725
United States | Pharmaceuticals
VYNE Gross Margin
As of 2025-05-30, the Gross Margin of Vyne Therapeutics Inc (VYNE) is 93.4%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
VYNE Gross Margin - Historical Value
| Date | Value |
|---|---|
| 2024-12-31 | 93.4% |
| 2023-12-31 | - |
| 2022-12-31 | - |
| 2021-12-31 | 77.3% |
| 2020-12-31 | 93.4% |
| 2019-12-31 | - |
| 2018-12-31 | - |
| 2017-12-31 | - |
| 2016-12-31 | - |
| 2015-12-31 | - |
VYNE Gross Margin - Peers Comparison